AZD7442 gets a name!: Earlier this month... - CLL Support

CLL Support

23,253 members39,949 posts

AZD7442 gets a name!

bennevisplace profile image
4 Replies

Earlier this month Astrazeneca applied to the FDA for an emergency use authorisation (EUA) for its long-acting monoclonal antibody cocktail AZD7442. The application is based on the results of the PROVENT phase 3 trial of the drug as a prophylactic against Covid19, backed up by laboratory studies, purporting to show the drug's neutralising activity against the Delta and Mu variants, and safety data from the STORM CHASER trials.

More recently Astrazeneca has begun submitting data to the European Medicines Agency (EMA) under a "Rolling Review" arrangement. This is a fairly common way of fast-tracking a promising drug towards a formal marketing authorisation, but it tells us that some of the key data are not yet there. My guess is that EMA/ Astrazeneca want to have enough subjects monitored for 12 months to be able to demonstrate that protection is indeed "long acting" as billed. Another requirement could be confirming real-world protection against the Delta variant, which appeared circa mid 2021 in the PROVENT trial locations.

Oh, the name. Evusheld. Really. ema.europa.eu/en/news/ema-s...

Written by
bennevisplace profile image
bennevisplace
To view profiles and participate in discussions please or .
4 Replies
blowinginthewind profile image
blowinginthewind

Are people on W&W eligible for this - I was diagnose 3 1/2 years ago and I haven't had treatment yet. The form says "diagnosed in the last year" but that is very vague when it comes to us with our CLL.

bennevisplace profile image
bennevisplace in reply toblowinginthewind

I'm not sure what you mean by "The form says.."

The only monoclonal antibody treatment so far authorised for UK use is Ronapreve. This Evusheld is intended to be used as a durable (6-12 months) prophylaxis, pre-infection. It's not yet approved anywhere.

blowinginthewind profile image
blowinginthewind in reply tobennevisplace

When I clicked the link on your post, it took me to information about who is eligible for the trial, and it said that it was for people diagnosed with cancer "with the last year" or who are having treatment or have had stem cell treatment. People with CLL on W&W for many years in some cases.

bennevisplace profile image
bennevisplace in reply toblowinginthewind

The link above is to the EMA website. Their article says nothing about a trial. I think you must have found that in another post. Maybe this one? healthunlocked.com/cllsuppo...

The PROVENT trial is listed as Active, not recruiting clinicaltrials.gov/ct2/show...

Not what you're looking for?

You may also like...

Breaking News! The AZD7442 PROVENT Phase III Prophylaxis Trial met its primary endpoint in preventing symptomatic COVID-19!

Clinical Trial Breaking News Today! CLL Society is delighted to share today's readout from the...
bkoffman profile image
CLL CURE Hero

Calling UK CLLers - Is government about to abandon support for protective monoclonal antibodies?

There is ample evidence now that many CLL patients don't respond well to vaccination against the...

STORM CHASER MISSES THE TARGET

Following hard on the heels of Regeneron, who just posted lukewarm results from the RECOVERY trial...

Ibrutinib Slow but steady foreward movement.

Slowly things move forwards… New Marketing Authorisation Application Submitted to EMA for...
Kwenda profile image

UK first to trial AstraZeneca 'antibody cocktail' aimed at non-vaccine patients

I'm not recruiting for Astrazeneca, but news broke this morning that they are to start phase 3...

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
Jm954 profile image
Jm954Administrator
AussieNeil profile image
AussieNeilAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.